Answer
Enerzair Breezhaler is indicated for maintenance treatment of asthma in adults inadequately controlled with a maintenance combination of a long-acting beta2-agonist and a high-dose inhaled corticosteroid who experienced at least one asthma exacerbation in the previous year.
Sources for this answer
- Enerzair BreezhalerNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 7Document updated
Sources checked